This Week’s Biopharma News: Big Moves in Bispecifics - Poll - MDSpire

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

  • June 9, 2026

  • 5 min

Share

Original Source(s)

This Week’s Biopharma News: Big Moves in Bispecifics

  • June 9, 2026

Related Content

Early risk stratification and temporal biomarker patterns of trousseau syndrome-related cerebral infarction in lung cancer

Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process

Chronic military stress and glandular epithelial tumor biology: an integrative neuroendocrine–inflammatory framework with insights from microgravity gene discovery